HOOKIPA Pharma Inc
NASDAQ:HOOK

Watchlist Manager
HOOKIPA Pharma Inc Logo
HOOKIPA Pharma Inc
NASDAQ:HOOK
Watchlist
Price: 0.88 USD -1.79% Market Closed
Market Cap: 10.9m USD

Relative Value

The Relative Value of one HOOK stock under the Base Case scenario is 2.61 USD. Compared to the current market price of 0.88 USD, HOOKIPA Pharma Inc is Undervalued by 66%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HOOK Relative Value
Base Case
2.61 USD
Undervaluation 66%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
88
vs Industry
92
Median 3Y
1.8
Median 5Y
34.1
Industry
7.8
Forward
0.4
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-7.5
Industry
24.1
Forward
-0.3
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-14.6
Industry
21.8
vs History
vs Industry
Median 3Y
-1
Median 5Y
-12
Industry
23.8
vs History
98
vs Industry
75
Median 3Y
0.9
Median 5Y
5.1
Industry
3.3
vs History
vs Industry
40
Median 3Y
-0.2
Median 5Y
26.3
Industry
8
Forward
-1.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.3
vs History
4
vs Industry
22
Median 3Y
0.2
Median 5Y
-5.4
Industry
6.3
Forward
0.3
vs History
4
vs Industry
20
Median 3Y
0.2
Median 5Y
-5.1
Industry
6.7
Forward
0.4
vs History
1
vs Industry
28
Median 3Y
0.2
Median 5Y
-11.9
Industry
7.9
vs History
1
vs Industry
23
Median 3Y
0.2
Median 5Y
-10.5
Industry
6.3
vs History
vs Industry
19
Median 3Y
-0.3
Median 5Y
8.1
Industry
5.5

Multiples Across Competitors

HOOK Competitors Multiples
HOOKIPA Pharma Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
HOOKIPA Pharma Inc
NASDAQ:HOOK
10.6m USD 1.1 -0.1 0.4 0.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 837 682.7 -160 825.5 -195 293.4 -193 064.9
US
Abbvie Inc
NYSE:ABBV
400.9B USD 6.7 170.7 16.5 23.4
US
Amgen Inc
NASDAQ:AMGN
176.1B USD 4.9 25.1 18.1 18.1
US
Gilead Sciences Inc
NASDAQ:GILD
154.4B USD 5.3 19 12.8 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 9.9 31.5 23.1 24.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 082 -531.3 -578.5 -563.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.9B USD 5.7 17.7 16.8 19.1
AU
CSL Ltd
ASX:CSL
84.8B AUD 3.6 18.7 12.6 15.7
NL
argenx SE
XBRU:ARGX
45B EUR 14.6 34.4 59.4 61.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.7B USD 16.4 1 210.8 159.1 192.9
P/E Multiple
Earnings Growth PEG
US
HOOKIPA Pharma Inc
NASDAQ:HOOK
Average P/E: 191
Negative Multiple: -0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 825.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
170.7
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.5
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
9%
2
AU
CSL Ltd
ASX:CSL
18.7
11%
1.7
NL
argenx SE
XBRU:ARGX
34.4
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 210.8
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
HOOKIPA Pharma Inc
NASDAQ:HOOK
Average EV/EBITDA: 35.4
0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 293.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.5
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.1
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.1
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
NL
argenx SE
XBRU:ARGX
59.4
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
159.1
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
HOOKIPA Pharma Inc
NASDAQ:HOOK
Average EV/EBIT: 40.9
0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 064.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.1
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.2
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.1
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
NL
argenx SE
XBRU:ARGX
61.1
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
192.9
N/A N/A